The Ukrainian military said it attacked the oil depot in the Bryansk region of Russia.Comments on Hong Kong stocks: Hang Seng Index fell by 0.77%, Hang Seng Technology Index fell by 1.31%, Hong Kong stocks closed, Hang Seng Technology Index fell by 0.77%, Hang Seng Technology Index fell by 1.31%, dropped by over 5%, and JD.COM Group and Meituan fell by over 2%.Governor of Belgorod, Russia: Ukrainian troops fired more than 30 shells in Belgorod within 24 hours, causing no casualties or property losses.
Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.On the 11th, soybean oil rose by 1.72%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract soybean oil closed at 2,505, up or down by +1.72%, with a turnover of 529,500 lots. The position data showed that the top 20 seats were clear, and the difference position was 59,880 lots. The total contract turnover of soybean oil futures was 685,800 lots, a decrease of 114,300 lots from the previous day. The first 20 seats in the contract held 687,800 lots, an increase of 15,900 lots over the previous day. The short positions in the top 20 seats of the contract were 775,600 lots, an increase of 3,312 lots over the previous day. (Sina Futures)The Taiwan Affairs Office of the State Council introduced the situation of the 2024 Shanghai-Taipei Twin Cities Forum. The Taiwan Affairs Office held a regular press conference. Spokesperson Zhu Fenglian said that it is understood that the 2024 Shanghai-Taipei Urban Forum will be held in Taipei on December 17, and Shanghai will send a delegation to Taiwan to attend the forum. With the theme of "Smart Governance for a Sustainable Future", the forum will promote the interactive exchanges between the two cities in terms of friendly transportation, river governance and humanistic cities. During the forum, the two cities will also sign a memorandum on exchanges and cooperation. We hope the forum will be successful.
Wuzhou Spring Festival rose by 6.55% today. Guotai Junan bought 188 million yuan in Shanghai Haiyang West Road, and Wuzhou Spring Festival rose by 6.55% today, with a turnover of 3.902 billion yuan and a turnover rate of 37.90%. After-hours data show that Guotai Junan bought 188 million yuan in Shanghai Haiyang West Road, and the special seat of Shanghai Stock Connect bought 88.9787 million yuan and sold 58.7513 million yuan.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14